These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2380405)

  • 1. Cholesterol absorption by the gall bladder.
    Ross PE; Butt AN; Gallacher C
    J Clin Pathol; 1990 Jul; 43(7):572-5. PubMed ID: 2380405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of cholesterol absorption by human gall bladder: relevance to cholesterolosis.
    Jacyna MR; Ross PE; Bakar MA; Hopwood D; Bouchier IA
    J Clin Pathol; 1987 May; 40(5):524-9. PubMed ID: 3584503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of accumulation of cholesterol in the gallbladder mucosa. Evidence that sterol 27-hydroxylase is not a pathogenetic factor.
    Strömsten A; von Bahr S; Bringman S; Saeki M; Sahlin S; Björkhem I; Einarsson C
    J Hepatol; 2004 Jan; 40(1):8-13. PubMed ID: 14672608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid composition of bile and gallbladder mucosa in patients with acalculous cholesterolosis.
    Tilvis RS; Aro J; Strandberg TE; Lempinen M; Miettinen TA
    Gastroenterology; 1982 Apr; 82(4):607-15. PubMed ID: 7060883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophilic bile salts and liposomes inhibit hydrophobic bile salt-induced release of glycoprotein by guinea-pig gall-bladder.
    Aihara N; Tazuma S; Kajiyama G
    J Gastroenterol Hepatol; 1995; 10(1):42-6. PubMed ID: 7620106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol metabolism in liver and gallbladder mucosa of patients with cholesterolosis.
    Sahlin S; Ståhlberg D; Einarsson K
    Hepatology; 1995 May; 21(5):1269-75. PubMed ID: 7737633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.
    Carey MC; Small DM
    J Clin Invest; 1978 Apr; 61(4):998-1026. PubMed ID: 659586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent secretion of abnormal bile in patients with cholesterol gall stones.
    Smallwood RA; Jablonski P; Watts JM
    Br Med J; 1972 Nov; 4(5835):263-6. PubMed ID: 5083887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
    Nakano K; Chijiiwa K
    Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial bile inhibits bile salt-induced gallbladder glycoprotein release in vitro.
    O'Leary DP
    Hepatology; 1994 Mar; 19(3):771-4. PubMed ID: 8119706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.
    Gollish SH; Burnstein MJ; Ilson RG; Petrunka CN; Strasberg SM
    Gut; 1983 Sep; 24(9):836-44. PubMed ID: 6884818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol saturation rather than phospholipid/bile salt ratio or protein content affects crystallization sequences in human gallbladder bile.
    Venneman NG; Portincasa P; Vanberge-Henegouwen GP; van Erpecum KJ
    Eur J Clin Invest; 2004 Oct; 34(10):656-63. PubMed ID: 15473890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of 'non-absorbable' markers and an improved method for determining cholesterol absorption rates.
    Jacyna MR; Ross PE; Gallacher C; Hill A; Hopwood D; Bouchier IA
    Br J Exp Pathol; 1988 Feb; 69(1):23-33. PubMed ID: 2450557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
    Lanzini A; Northfield TC
    Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallbladder function, cholesterol stones, and bile composition.
    Antsaklis G; Lewin MR; Sutor DJ; Cowie AG; Clark CG
    Gut; 1975 Dec; 16(12):937-42. PubMed ID: 1218816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
    Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
    Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physicochemical basis of cholesterol gallstone formation in man.
    Admirand WH; Small DM
    J Clin Invest; 1968 May; 47(5):1043-52. PubMed ID: 5645851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile salt hydrophobicity controls vesicle secretion rates and transformations in native bile.
    Cohen DE; Leighton LS; Carey MC
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G386-95. PubMed ID: 1415551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I in bile inhibits cholesterol crystallization and modifies transcellular lipid transfer through cultured human gall-bladder epithelial cells.
    Secknus R; Darby GH; Chernosky A; Juvonen T; Moore EW; Holzbach RT
    J Gastroenterol Hepatol; 1999 May; 14(5):446-56. PubMed ID: 10355509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol and bile salt studies on the bile of patients with cholesterol gallstones.
    Heller F; Bouchier IA
    Gut; 1973 Feb; 14(2):83-8. PubMed ID: 4696536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.